Literature DB >> 30536939

High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.

Kwai Fung Hui1, Tsz Fung Chan1, Wanling Yang1,2, Jiangshan Jane Shen1, Ki Pui Lam1, Hin Kwok3, Pak C Sham2,3, Sai Wah Tsao2,4, Dora L Kwong2,5, Maria Li Lung2,5, Alan Kwok Shing Chiang1,2.   

Abstract

Whether certain variants of Epstein-Barr virus (EBV) are linked to the pathogenesis of nasopharyngeal carcinoma (NPC), which shows a marked geographic restriction, remains an unresolved issue. We performed a case-control study comparing genomic sequences of EBV isolated from saliva samples of 142 population carriers with those from primary tumour biopsies derived from 62 patients with NPC of Hong Kong. Cluster analysis discovered five EBV subgroups 1A-C and 2A-B amongst the population carriers in contrast to the predominance of 1A and -B in the majority of NPC. Genome-wide association study (GWAS) identified a panel of NPC-associated single nucleotide polymorphisms (SNPs) and indels in the EBER locus. The most significant polymorphism, which can be found in 96.8% NPC cases and 40.1% population carriers of Hong Kong, is a four-base-deletion polymorphism downstream of EBER2 (EBER-del) from coordinates 7188-7191 (p = 1.91 × 10-7 ). In addition, the predicted secondary structure of EBER2 is altered with likely functional consequence in nearly all NPC cases. Using the SNPs and indels associated with NPC, genetic risk score is assigned for each EBV variant. EBV variants with high genetic risk score are found to be much more prevalent in Hong Kong Chinese than individuals of other geographic regions and in NPC than other EBV-associated cancers. We conclude that high risk EBV variants with polymorphisms in the EBER locus, designated as HKNPC-EBERvar, are strongly associated with NPC. Further investigation of the biological function and potential clinical application of these newly identified polymorphisms in NPC and other EBV-associated cancers is warranted.
© 2018 UICC.

Entities:  

Keywords:  EBV-encoded small RNA; Epstein-Barr virus; HKNPC-EBERvar; genome-wide analysis; nasopharyngeal carcinoma; sequencing

Mesh:

Substances:

Year:  2019        PMID: 30536939     DOI: 10.1002/ijc.32049

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives In Vivo Expansion of Latently Infected B Cells.

Authors:  Yiping Wang; Nathan Ungerleider; Brett A Hoffman; Mehmet Kara; Paul J Farrell; Erik K Flemington; Nara Lee; Scott A Tibbetts
Journal:  mBio       Date:  2022-06-01       Impact factor: 7.786

2.  EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non-endemic region.

Authors:  Satoru Kondo; Yusuke Okuno; Takayuki Murata; Hirotomo Dochi; Naohiro Wakisaka; Harue Mizokami; Makiko Moriyama-Kita; Eiji Kobayashi; Makoto Kano; Takeshi Komori; Nobuyuki Hirai; Takayoshi Ueno; Yosuke Nakanishi; Kazuhira Endo; Hisashi Sugimoto; Hiroshi Kimura; Tomokazu Yoshizaki
Journal:  Cancer Sci       Date:  2022-05-24       Impact factor: 6.518

3.  Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL).

Authors:  Racha Bahri; François Boyer; Mohamad Adnan Halabi; Alain Chaunavel; Jean Feuillard; Arnaud Jaccard; Sylvie Ranger-Rogez
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

4.  Genomic Landscapes of Epstein-Barr Virus in Pulmonary Lymphoepithelioma-Like Carcinoma.

Authors:  Yan-Xia Wu; Wen-Li Zhang; Tong-Min Wang; Ying Liao; Yi-Jun Zhang; Ruo-Wen Xiao; Yi-Jing Jia; Zi-Yi Wu; Chang-Mi Deng; Da-Wei Yang; Wen-Qiong Xue; Yong-Qiao He; Xiao-Hui Zheng; Xi-Zhao Li; Ting Zhou; Pei-Fen Zhang; Shao-Dan Zhang; Ye-Zhu Hu; Jiang-Bo Zhang; Wei-Hua Jia
Journal:  J Virol       Date:  2021-12-15       Impact factor: 6.549

5.  Human herpesvirus diversity is altered in HLA class I binding peptides.

Authors:  William H Palmer; Marco Telford; Arcadi Navarro; Gabriel Santpere; Paul J Norman
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-29       Impact factor: 12.779

Review 6.  Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: History and risk factors.

Authors:  Reagan Entigu Linton; Maelinda Daker; Alan Soo-Beng Khoo; Diana Chung Yiing Choo; Mignon Viljoen; Paul M Neilsen
Journal:  Oncol Lett       Date:  2021-05-06       Impact factor: 2.967

Review 7.  Treatment Advances in EBV Related Lymphoproliferative Diseases.

Authors:  Kebing Lv; Ting Yin; Min Yu; Zhiwei Chen; Yulan Zhou; Fei Li
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

Review 8.  Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.

Authors:  Pok Man Hau; Hong Lok Lung; Man Wu; Chi Man Tsang; Ka-Leung Wong; Nai Ki Mak; Kwok Wai Lo
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

9.  Epstein-Barr virus ncRNA from a nasopharyngeal carcinoma induces an inflammatory response that promotes virus production.

Authors:  Zhe Li; Ming-Han Tsai; Anatoliy Shumilov; Francesco Baccianti; Sai Wah Tsao; Remy Poirey; Henri-Jacques Delecluse
Journal:  Nat Microbiol       Date:  2019-09-09       Impact factor: 17.745

10.  Comprehensive Evolutionary Analysis of Complete Epstein-Barr Virus Genomes from Argentina and Other Geographies.

Authors:  Ana Catalina Blazquez; Ariel José Berenstein; Carolina Torres; Agustín Izquierdo; Carol Lezama; Guillermo Moscatelli; Elena Noemí De Matteo; Mario Alejandro Lorenzetti; María Victoria Preciado
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.